The reduction of NPTX2 that is correlated with cognitive decline implicates a pathophysiological mechanism – failure of the adaptive function of pyramidal neurons to modify excitatory drive of fast spiking parvalbumin (PV) interneurons- that could potentially be targeted for therapeutics [42]. This evidence concerns the gene NPTX2 and Mental deterioration.